“We are talking about sex and drugs—two topics that people call taboo,” said Brigitte Quenum, UNAIDS Regional Team Lead for ...

Gilead Sciences ( GILD) increased its growth forecast for the year on strong third quarter results, marking a shift away from ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Gammora was shown to be safe and effective in eliminating HIV-infected cells without harming surrounding uninfected cells, ...

ViiV Healthcare chief medical officer Harmony Garges said: “We know taking fewer medicines is an important consideration for ...

Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...

The centre specialises mainly in heroin addiction and in assisting drug users to be reincorporated into society. The site coordinator, Alfred Majara, spoke to the HERAUT regarding the new centre and .

New Drug Shows Promise in Clearing HIV from Brain July 25, 2024 — An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a ...

In March 2013, the government-run drug rehab Hanoi released Hung Quang Pham early. They didn’t want the bone-thin heroin user ...

for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. Raltegravir Tablets USP, 600 mg are indicated ...

Data from the Centers for Disease Control and Prevention released Tuesday shows meaningful declines in STI rates between 2022 ...

Dolutegravir is an HIV integrase strand transfer inhibitor ... enzymes and therefore is associated with few drug interactions other than metformin and dofetilide. Dolutegravir should be ...